HARROW, INC.
HROW · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Shojaei Amir: Form 4
Insider disclosure · Filed · Report period 14 Aug 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- HROW · 415858109 - Common Stock
Company details and SEC sources
CIK 0001360214 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- HROW on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1 A Burton Hills Blvd, Suite 200, Nashville, TN
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
-
HARROW HEALTH INC. (to 20 Sep 2023) Imprimis Pharmaceuticals Inc. (to 17 Dec 2018) TRANSDEL PHARMACEUTICALS INC (to 27 Feb 2012) Bywater Resources Inc (to 12 Sep 2007)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields